1
-
2
of
2
results (0.23 seconds)
Sort By:
-
2023-health-meeting-session-2c
Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore ...- Authors: Society of Actuaries
- Date: Dec 2023
- Competency: Results-Oriented Solutions
- Topics: Actuarial Profession; Experience Studies & Data; Financial Reporting & Accounting; Modeling & Statistical Methods; Predictive Analytics; Reinsurance
-
2021 Life Meeting - Session 2F: LDTI Data - Actuarial and IT Partnership Roundtable 8.30.21 Recording
Implementing the new data and system requirements related to LDTI bring a renewed focus on the partnership between actuarial and IT teams. This session will discuss common challenges encountered ...
- Authors: Society of Actuaries
- Date: Oct 2021
- Competency: Results-Oriented Solutions
- Topics: Reinsurance